Chemistry of 6-methyluracile and antitumour activity of its new derivatives

  • E.V. Welchinska -
  • I.V. Nizenkovskaya -
  • N.I. Sharykina -
Keywords: 6-methyluracile, ftorotan, tumor, crown-ether

Abstract

A new convenient methods for the preparation with 18-crown-6-complex as catalyst of original hete­rocycles on the base of 6-methyluracile and fluoric containing sintones — common anesthetic ftorotan and 1,1 -diethylcarboxy-2-chloro-2-threefluoro-methylethylene were described. The structure and composition of synthesized compound has been confirmed by data of elemental analysis, IR- and NMR 1H -spectra. It was discovered that compounds which synthesized — mono- and bis-derivatives of 6-methyluracile applies to a little toxic preparations: its LD50 are at the interval from 580 mg/kg to 465 mg/kg. A strongly antitumour effect of bis-derivative of 6-methyluracile on Lymphosarcoma Plissa tumour with growth relaxation of tumor mass 72,5 % (the criteria of considerable are ≥ 50 %) has been registered.

References

1. Mashkovsky DS Agents that affect the central nervous system. - K .: Naukova Dumka, 1991. - P. 43-44.
2. Mndoyan A.L., Ter-Zakharyan Y.Z. Biological properties of chemical compounds. - Yerevan: Ed. AN Arm. SSR, 1962. - Issue. 1. - 246 p.
3. Prozorovsky VB, Prozorovsky VP, Demchenko VM // Pharmacol. and toxicol. - 1978. - T. 41, No. 4. - P. 407-509.
4. Experimental evaluation of anticancer drugs in the USSR and the USA / Ed. ZP Sofina, AB Syrkin, A. Goldin, A. Klein. - M .: Medicine, 1979. - 296 p.
5. Yagupolsky LM Aromatic and heterocyclic compounds with fluorine-containing substituents. - K .: Scientific Thought, 1988. - P. 90 -105.
6. Adjei A. A review of pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer / A. Adjei // Clin, Pharmacol. - 1999. Vol. 48. P. 265-227.
7. Brody G.L. Halothane anesthesia as a possible cause of massive hepatic necrosis / G.L Brody, R.B. Sweet // Anesthesiol. - 1963 - Vol. 24. P. 29 37.
8. Brown B.R. Biotransformation and hepatotoxicity of halothane / B.R. Brown, I.G. Sipes // Biochem. Pharmacol. - 1977 - Vol. 26. P. 2091-2094.
9. Longley D.B. Mechanisms of action of 5-fluorouracil / D.B. Longley, D.P. Harkin // Nature Rev. Cancer. - 2004, -Vol. 4. P. 230-238.
10. Noordhuis P. 5-fluorouracil incorporation info RNA and DNA in relation to thymidylate synthetase inhibition of human colorectal cancer / P. Noordhuis, U. Holwerda // Annals. of oncol. - 2004. - Vol. 15. P. 1025-1032.
11. Orjales A. New 2-piperaznylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmaco¬logical evaluation / A. Orjales, R. Mosquera, L. Labeage, R. Rodes // J. Med. Chum. - 1997 - Vol. 40, N4. P. 586-593.
12. Welchinska Hel.V., B. Piecuszak, E.A. Коваленко, Н.И. Sharykina et al. // Microbiol. . - 2003. - T. 65, №6, - P. 20-25.
Published
2019-10-29
How to Cite
Welchinska, E., Nizenkovskaya, I., & Sharykina, N. (2019). Chemistry of 6-methyluracile and antitumour activity of its new derivatives. Farmatsevtychnyi Zhurnal, (4), 87-91. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/785
Section
Practical pharmacy